The goal of aptitude LLC, the Amazon.com-style marketplace for medical device companies and hospitals, is to reduce costs while speeding up contracting in the healthcare supply chain for buyers and sellers of medical equipment.
Sales
J&J’s Synthes wins another round against Globus, ex-sales rep
Zimmer accuses Stryker, ex-sales rep of ‘Trojan Horse’ poaching scheme
Diabetes: Insulet to hire 20 new sales reps as pediatric pump sales soar
Medtronic, Stryker and Boston Scientific rank among best sales jobs in medtech
Aptitude adds more than 100 hospitals to portfolio
Aptitude LLC said it inked a deal with the Northeast Purchasing Coalition for online direct contracting for more than 100 hospitals.
Aptitude is an online marketplace aimed at streamlining the hospital purchasing process by connecting medical device suppliers with their counterparts in the hospital industry. The company is a spinout of Irving, Texas-based group purchasing organization Novation.
Is premium pricing a thing of the past? | MassDevice.com On Call
MASSDEVICE ON CALL — In the pre-Obamacare world, medical device companies were able to price their products at a premium, justified by improvements in quality that were in some cases marginal. But premium pricing "typically becomes an easy target for disruption through product innovation in many other technology industries, especially when the market place is crowded with competitors," writes Mohit Kaushal, a partner at Aberdare Ventures in San Francisco.
Siemens Healthcare inks outside sales deal
Siemens Healthcare (NYSE:SI) inked a deal with outside sales firm NGage to complement its in-house sales efforts.
Malvern, Pa.-based Siemens hired NGage U.S. to a 5-year pact to bolster the direct sales team for its women’s health and diagnostic imaging products.
Medical devices and the Great Deflation
The medical device industry has "lost" about $131 billion in revenues since the financial collapse of 2008, according to analysts at Ernst & Young.
The findings, taken from the audit firm’s annual "Pulse of the Industry" report, paint a glum picture for the medtech industry, once considered to be "recession proof."